LTI
REGN icon

Laffer Tengler Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Laffer Tengler Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$11.6K – 314
2024
Q2 		$11.6K Hold
11
– – ﹤0.01% 307
2024
Q1 		$10.6K Hold
11
– – ﹤0.01% 299
2023
Q4 		$9.66K Hold
11
– – ﹤0.01% 272
2023
Q3 		$9.05K Sell
11
-2,443
-100% -$1.92M ﹤0.01% 281
2023
Q2 		$1.76M Sell
2,454
-52
-2% -$40.1K 0.47% 73
2023
Q1 		$2.06M Buy
2,506
+86
+4% +$64.9K 0.56% 68
2022
Q4 		$1.75M Buy
2,420
+90
+4% +$66.4K 0.5% 66
2022
Q3 		$1.61M Buy
2,330
+43
+2% +$27.1K 0.59% 69
2022
Q2 		$1.35M Sell
2,287
-43
-2% -$28K 0.47% 82
2022
Q1 		$1.63M Sell
2,330
-43
-2% -$27.2K 0.49% 81
2021
Q4 		$1.5M Buy
2,373
+266
+13% +$164K 0.43% 89
2021
Q3 		$1.28M Buy
2,107
+411
+24% +$255K 0.37% 103
2021
Q2 		$947K Buy
1,696
+1,269
+297% +$643K 0.36% 93
2021
Q1 		$202K Buy
427
+47
+12% +$22.9K 0.08% 154
2020
Q4 		$182K Buy
+380
New +$205K 0.08% 160
2016
Q2 		– Sell
-4,353
Closed -$1.57M – 258
2016
Q1 		$1.57M Buy
+4,353
New +$1.79M 0.42% 111
2015
Q4 		– Hold
0
– – – 42
2015
Q3 		– Sell
-4,353
Closed -$2.34M – 48
2015
Q2 		$2.22M Buy
+4,353
New +$2.12M 0.54% 42

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Laffer Tengler Investments's REGN Position: Q3 2024 in Review

Laffer Tengler Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 11 shares — an estimated $11.6K sold.

Laffer Tengler Investments first reported a position in REGN in Q2 2015 and held it in 17 quarters. The position peaked at $2.22M in Q2 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Laffer Tengler Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Laffer Tengler Investments sold 11 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $11.6K.
  • Laffer Tengler Investments first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 17 quarters.
  • Laffer Tengler Investments's Regeneron Pharmaceuticals position peaked at $2.22M in Q2 2015.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Laffer Tengler Investments's 13F filing for Q3 2024, filed 4 Nov 2024.